Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms. (2021)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41375-021-01300-7
PubMed Identifier: 34023850
Publication URI: http://europepmc.org/abstract/MED/34023850
Type: Journal Article/Review
Volume: 35
Parent Publication: Leukemia
Issue: 12
ISSN: 0887-6924